BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3835769)

  • 1. [Evaluation of the stability of lyophilized factor IX concentrate].
    Hoffmann S; Bykowska K; Lukasiak S; Lopaciuk S
    Acta Haematol Pol; 1985; 16(3-4):135-8. PubMed ID: 3835769
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro stability studies of a Factor IX concentrate (Bebulin).
    Dal Bo Zanon R; Gazzetta R; Patrassi G; Stocco D; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(6):874-8. PubMed ID: 6200399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Concentrate of coagulation factor IX: viral validation of the thermoinactivation process].
    Zahorska R; Buchowicz I; Ejduk A
    Acta Haematol Pol; 1995; 26(4):421-4. PubMed ID: 8571744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stability of factor IX concentrate during storage.
    Suomela H; Vahtera E
    Thromb Haemost; 1982 Apr; 47(2):114-5. PubMed ID: 7101229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two stability programs for lyophilized coenzyme B12 in ampoules.
    Colombo BM; Causa P; Primavera P
    Arzneimittelforschung; 1971 Jan; 21(1):93-5. PubMed ID: 5108206
    [No Abstract]   [Full Text] [Related]  

  • 6. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11).
    Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S
    Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The formulation of recombinant factor IX: stability, robustness, and convenience.
    Bush L; Webb C; Bartlett L; Burnett B
    Semin Hematol; 1998 Apr; 35(2 Suppl 2):18-21. PubMed ID: 9565162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heat stability of a lyophilized inactivated anti-rabies-vaccine].
    Jaeger O; Barth R
    Zentralbl Bakteriol Orig; 1969 May; 210(1):135-9. PubMed ID: 5361074
    [No Abstract]   [Full Text] [Related]  

  • 9. [For better stability of lyophilized drugs. Recent technological development in pre-freezing].
    Rigoli A
    Boll Chim Farm; 1974 Sep; 113(9):461-6. PubMed ID: 4447684
    [No Abstract]   [Full Text] [Related]  

  • 10. [The way to long-term ambient temperature stabilization of biologicals--freeze-drying and evaporative-drying with vitrification].
    Franks F; Terashima M
    Tanpakushitsu Kakusan Koso; 1996 May; 41(6):810-6. PubMed ID: 8787051
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stability of lyophilized smallpox vaccine after more than 3 years of storage in temperatures of the environment].
    Kühn O
    Z Gesamte Hyg; 1967 Jul; 13(7):487-93. PubMed ID: 5594126
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of amino acid stabilities in casein hydrolysate solution and in lyophilized casein hydrolysate samples under various storage conditions.
    Friend JE; Stegink LD; Kann DE
    Am J Hosp Pharm; 1972 Oct; 29(10):835-9. PubMed ID: 5075123
    [No Abstract]   [Full Text] [Related]  

  • 13. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
    Anhorn MG; Mahler HC; Langer K
    Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stability of the Romanian freeze-dried BCG vaccine.
    Balazs D; Piţur I; Drăghici D
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):141-6. PubMed ID: 7149960
    [No Abstract]   [Full Text] [Related]  

  • 15. [Freeze drying methods for smallpox cell culture vaccines].
    Herrero E; Meggers R
    Zentralbl Bakteriol Orig; 1968; 209(1):1-9. PubMed ID: 5746321
    [No Abstract]   [Full Text] [Related]  

  • 16. Heat stability of the lyophilized Sabin poliovaccine.
    Shiomi H; Urasawa T; Urasawa S
    Jpn J Infect Dis; 2003 Apr; 56(2):70-2. PubMed ID: 12824691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stability of enzymes inactivating aminoglycoside antibiotics].
    Taisova AS; Griaznova NS
    Antibiotiki; 1984 Sep; 29(9):649-53. PubMed ID: 6095748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the stability of Brucella abortus strain 19 reduced dosage lyophilized vaccines produced by different methods.
    Angus RD
    Dev Biol Stand; 1984; 56():659-78. PubMed ID: 6436119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 20. Stability of Russell's viper venom toxoid (lyophilized form) on storage.
    Aung W; Hlaing KK; Kyaw KP; Win MM; Kyaw A
    Jpn J Infect Dis; 1999 Dec; 52(6):234-7. PubMed ID: 10738360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.